HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) All Versions of this Article: 290/4/R909    most recent 00045.2005v1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Web of Science (2) Citing Articles via Google Scholar Google Scholar Articles by Lin, L. Articles by York, D. A. Search for Related Content PubMed PubMed Citation Articles by Lin, L. Articles by York, D. A.

APPETITE, OBESITY, DIGESTION, AND METABOLISM

Different metabolic responses to central and peripheral injection of enterostatin

Pennington Biomedical Research Center, Baton Rouge, Louisiana

Submitted 21 January 2005 ; accepted in final form 4 June 2005

Enterostatin, a pentapeptide cleaved from procolipase, suppresses fat intake after peripheral and central administration. Chronic treatment of rats with enterostatin decreases body weight and body fat. The effect was greater than could be accounted by the reduction in food intake alone. Hence, we have investigated the effect of enterostatin on energy metabolism. Male Sprague-Dawley rats adapted to a high-fat diet were implanted with lateral cerebral ventricular or amygdala cannulas. The metabolic effects were determined by indirect calorimetry. After habituation to the test cages, fasted rats were injected with either saline vehicle or enterostatin given either intraperitoneally (100 nmol) or intracerebroventricularly (1 nmol) or into specific brain regions [amygdala (0.01 nmol) or paraventricular nucleus (PVN) (0.1 nmol)]. Respiratory quotient (RQ) and energy expenditure were monitored over 2 h. Intraperitoneal enterostatin reduced RQ (saline: 0.81 ± 0.02 vs. enterostatin: 0.76 ± 0.01) and increased energy expenditure by 44%. Intracerebroventricular enterostatin increased the energy expenditure without any effects on RQ, whereas PVN enterostatin increased metabolic rate, while preventing the increase in RQ observed in the control animals. In contrast, neither RQ nor energy expenditure was altered after enterostatin was injected into the amygdala. Enterostatin activated AMP-activated protein kinase in primary cultures of human myocytes in a dose- and time-dependent manner and increased the rate of fatty acid -oxidation. These findings suggest that enterostatin regulates energy expenditure and substrate partitioning through both peripheral and central effects.

amygdala; indirect calorimetric system; respiratory quotient; adenosine 5'-diphosphate-active protein kinase; myocytes; -oxidation

This article has been cited by other articles:

				R. Miller, D. D'Agostino, C. Erlanson-Albertsson, and M. E. Lowe Enterostatin deficiency increases serum cholesterol but does not influence growth and food intake in mice Am J Physiol Endocrinol Metab, October 1, 2009; 297(4): E856 - E865. [Abstract] [Full Text] [PDF]